New Key Statistics Module, Z-Score and F-Score
NYSE:ABT Key Ratios
Market Cap $ M | 177,773.17 |
Enterprise Value $ M | 185,708.17 |
P/E(ttm) | 31.83 |
PE Ratio without NRI | 23.28 |
Forward PE Ratio | 21.98 |
Price/Book | 4.58 |
Price/Sales | 4.43 |
Price/Free Cash Flow | 36.28 |
Price/Owner Earnings | 40.79 |
Payout Ratio % | 0.47 |
Revenue (TTM) $ M | 40,326.00 |
EPS (TTM) $ | 3.21 |
Beneish M-Score | -2.48 |
10-y EBITDA Growth Rate % | 11.80 |
5-y EBITDA Growth Rate % | 11.50 |
y-y EBITDA Growth Rate % | -3.30 |
EV-to-EBIT | 25.93 |
EV-to-EBITDA | 17.85 |
PEG | 2.02 |
Shares Outstanding M | 1,739.63 |
Net Margin (%) | 13.96 |
Operating Margin % | 15.76 |
Pre-tax Margin (%) | 16.21 |
Quick Ratio | 1.11 |
Current Ratio | 1.60 |
ROA % (ttm) | 7.71 |
ROE % (ttm) | 14.89 |
ROIC % (ttm) | 10.32 |
Dividend Yield % | 2.07 |
Altman Z-Score | 4.95 |
ABT Number of Guru Trades
ABT Volume of Guru Trades
Gurus Latest Trades with NYSE:ABT
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NYSE:ABT is held by these investors
Total 7
Abbott Laboratories Insider Transactions
No Available Data
News about NYSE:ABT
Total 0- 1